NO985412L - Type-2 kjemokinbindende proteiner og anvendelser derav - Google Patents

Type-2 kjemokinbindende proteiner og anvendelser derav

Info

Publication number: NO985412L
Authority: NO; Norway
Prior art keywords: type; chemokine binding; binding proteins; poxviruses; cbp
Prior art date: 1996-05-22

Application number

NO985412A

Other languages

English (en)

Norwegian (no)

Other versions

NO985412D0 (no

Inventor

Grant Mcfadden

Alexandra Lucas

Original Assignee

Univ Alberta

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-05-22

Filing date

1998-11-20

Publication date

1999-01-20

1998-11-20 Application filed by Univ Alberta filed Critical Univ Alberta

1998-11-20 Publication of NO985412D0 publication Critical patent/NO985412D0/no

1999-01-20 Publication of NO985412L publication Critical patent/NO985412L/no

Links

102000027005 chemokine binding proteins Human genes 0.000 title abstract 2
108091008503 chemokine binding proteins Proteins 0.000 title 1
101710172503 Chemokine-binding protein Proteins 0.000 abstract 1
241000700564 Rabbit fibroma virus Species 0.000 abstract 1
230000001154 acute effect Effects 0.000 abstract 1
125000003275 alpha amino acid group Chemical group 0.000 abstract 1
230000001684 chronic effect Effects 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
230000028709 inflammatory response Effects 0.000 abstract 1
102000004169 proteins and genes Human genes 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1
208000011580 syndromic disease Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Oncology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Epidemiology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Application Of Or Painting With Fluid Materials (AREA)
Catalysts (AREA)

NO985412A 1996-05-22 1998-11-20 Type-2 kjemokinbindende proteiner og anvendelser derav NO985412L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US1813796P	1996-05-22	1996-05-22
PCT/US1997/008590 WO1997044054A2 (en)	1996-05-22	1997-05-21	Type-2 chemokine binding proteins and methods of use therefor

Publications (2)

Publication Number	Publication Date
NO985412D0 NO985412D0 (no)	1998-11-20
NO985412L true NO985412L (no)	1999-01-20

Family

ID=21786445

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO985412A NO985412L (no)	1996-05-22	1998-11-20	Type-2 kjemokinbindende proteiner og anvendelser derav

Country Status (20)

Country	Link
EP (1)	EP0901379B1 (de)
JP (1)	JP2000511535A (de)
KR (1)	KR20000015895A (de)
CN (1)	CN1226171A (de)
AT (1)	ATE196091T1 (de)
AU (1)	AU3136197A (de)
BR (1)	BR9710028A (de)
CA (1)	CA2256568A1 (de)
CZ (1)	CZ378998A3 (de)
DE (1)	DE69703040T2 (de)
DK (1)	DK0901379T3 (de)
ES (1)	ES2152095T3 (de)
GR (1)	GR3034805T3 (de)
IL (1)	IL127166A0 (de)
NO (1)	NO985412L (de)
NZ (1)	NZ333456A (de)
PL (1)	PL330149A1 (de)
PT (1)	PT901379E (de)
TR (1)	TR199802392T2 (de)
WO (1)	WO1997044054A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19853487A1 (de)	1998-11-19	2000-05-25	Fumapharm Ag Muri	Verwendung von Dialkylfumaraten
GB9916703D0 (en) *	1999-07-16	1999-09-15	Alcami Antonio	Viral protein binding compositions and methods
AU2001261738A1 (en) *	2000-05-17	2001-11-26	London Health Sciences Centre	Compositions and methods for promoting immunosuppression
US7118737B2 (en)	2000-09-08	2006-10-10	Amylin Pharmaceuticals, Inc.	Polymer-modified synthetic proteins
ATE500838T1 (de)	2000-09-08	2011-03-15	Amylin Pharmaceuticals Inc	ßPSEUDOß-NATIVE CHEMISCHE LIGATION
AU1174402A (en)	2000-10-11	2002-04-22	Viron Therapeutics Inc	Nucleic acid molecules and polypeptides for immune modulation
DK1339737T3 (da) *	2000-12-04	2007-10-15	Viron Therapeutics Inc	Immunomodulatorisk protein dannet ud fra Yaba-abetumorvirus
US7718368B2 (en)	2000-12-04	2010-05-18	Viron Therapeutics Inc.	Immunomodulatory protein and useful embodiments thereof
DE10162869A1 (de) *	2001-12-20	2003-07-31	Alexander Cherkasky	Invasive lineare halb-zyklische und zyklische Systeme zur Herauslockung der Krankheitserreger
GB0304531D0 (en) *	2003-02-27	2003-04-02	Isis Innovation	Treatment
WO2004103294A2 (en) *	2003-05-15	2004-12-02	Tanox, Inc.	Methods and compositions for the prevention and treatment of sepsis
WO2005023241A1 (en)	2003-09-09	2005-03-17	Fumapharm Ag	The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma
DK2653873T3 (da)	2007-02-08	2022-07-25	Biogen Ma Inc	Sammensætninger og anvendelser til behandling af multipel sklerose
CN113234137B (zh) *	2021-06-21	2022-02-25	华中农业大学	分离自草鱼的CXCL20a蛋白在作为抗菌肽中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU646695B2 (en) *	1990-04-09	1994-03-03	Immunex Corporation	Isolated viral protein cytokine antagonists
US5834419A (en) *	1995-04-19	1998-11-10	The John P. Robarts Institute	Chemokine binding protein and methods of use therefor
NZ320889A (en) *	1995-09-29	2000-09-29	Immunex Corp	A p35 protein which binds to and inhibits chemokines

1997
- 1997-05-21 WO PCT/US1997/008590 patent/WO1997044054A2/en not_active Ceased
- 1997-05-21 ES ES97926647T patent/ES2152095T3/es not_active Expired - Lifetime
- 1997-05-21 DK DK97926647T patent/DK0901379T3/da active
- 1997-05-21 JP JP09542675A patent/JP2000511535A/ja active Pending
- 1997-05-21 PT PT97926647T patent/PT901379E/pt unknown
- 1997-05-21 IL IL12716697A patent/IL127166A0/xx unknown
- 1997-05-21 BR BR9710028A patent/BR9710028A/pt not_active Application Discontinuation
- 1997-05-21 CA CA002256568A patent/CA2256568A1/en not_active Abandoned
- 1997-05-21 EP EP97926647A patent/EP0901379B1/de not_active Expired - Lifetime
- 1997-05-21 KR KR1019980709446A patent/KR20000015895A/ko not_active Withdrawn
- 1997-05-21 NZ NZ333456A patent/NZ333456A/xx unknown
- 1997-05-21 DE DE69703040T patent/DE69703040T2/de not_active Expired - Fee Related
- 1997-05-21 TR TR1998/02392T patent/TR199802392T2/xx unknown
- 1997-05-21 AT AT97926647T patent/ATE196091T1/de not_active IP Right Cessation
- 1997-05-21 AU AU31361/97A patent/AU3136197A/en not_active Abandoned
- 1997-05-21 PL PL97330149A patent/PL330149A1/xx unknown
- 1997-05-21 CN CN97196663A patent/CN1226171A/zh active Pending
- 1997-05-21 CZ CZ983789A patent/CZ378998A3/cs unknown
1998
- 1998-11-20 NO NO985412A patent/NO985412L/no not_active Application Discontinuation
2000
- 2000-11-10 GR GR20000402492T patent/GR3034805T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
DK0901379T3 (da)	2000-12-27
PT901379E (pt)	2001-02-28
CN1226171A (zh)	1999-08-18
WO1997044054A2 (en)	1997-11-27
WO1997044054A3 (en)	1998-05-14
CZ378998A3 (cs)	1999-07-14
EP0901379A2 (de)	1999-03-17
PL330149A1 (en)	1999-04-26
CA2256568A1 (en)	1997-11-27
AU3136197A (en)	1997-12-09
NO985412D0 (no)	1998-11-20
BR9710028A (pt)	1999-08-10
NZ333456A (en)	2000-08-25
HK1017622A1 (en)	1999-11-26
IL127166A0 (en)	1999-09-22
EP0901379B1 (de)	2000-09-06
KR20000015895A (ko)	2000-03-15
GR3034805T3 (en)	2001-02-28
JP2000511535A (ja)	2000-09-05
ATE196091T1 (de)	2000-09-15
DE69703040D1 (de)	2000-10-12
TR199802392T2 (xx)	1999-02-22
ES2152095T3 (es)	2001-01-16
DE69703040T2 (de)	2001-05-03

Legal Events

Date	Code	Title	Description
2004-01-19	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
DK0840615T3 (da)	2003-08-18	Kemokin-bindende protein og fremgangsmåder til anvendelse deraf
NO985412D0 (no)	1998-11-20	Type-2 kjemokinbindende proteiner og anvendelser derav
IL161016A (en)	2014-07-31	Polypeptides capable of ang-2 binding
DE60140773D1 (de)	2010-01-21	Polypeptide zur Bindung an das B-Lymphozyten-stimulatorische Protein (BLyS)
BG104149A (bg)	2000-08-31	Белтъци, свързващи интерлевкин-18, тяхното получаване и приложение
ATE255906T1 (de)	2003-12-15	Antikörper gegen cd40
BR0009206A (pt)	2001-12-26	Isolamento e análise de proteina
DE69833014D1 (de)	2006-02-02	Menschliche toll homologen
DK1017715T3 (da)	2008-10-06	Kimært polypeptid der omfatter fragment B af shiga-toksin og peptider af terapeutisk interesse
WO1999020760A3 (en)	1999-07-08	Herg family potassium ion channel genes and protein
PT906268E (pt)	2002-05-31	Fluorenonas com substituicao alquiloxiamino e sua utilizacao como inibidores da proteina quinase c
WO1997044451A3 (en)	1998-02-19	Vasoactive amine binding molecules
ATE550345T1 (de)	2012-04-15	Sfrp, mit sfrp-interagierende peptidmotive sowie verwendungsverfahren
ATE301194T1 (de)	2005-08-15	Beta-defensine
PT723552E (pt)	2003-02-28	Oligopeptidos derivados de fragmentos de proteina reactiva c
FI971086A7 (fi)	1997-03-14	Kinaasia sitova proteiini ja sen käyttö
BR0315222A (pt)	2005-08-23	Promotor de il-18bp, sua preparação e uso
DK223290A (da)	1990-09-18	Hidtil ukendt protein til konstatering af draegtighed hos pattedyr, anvendelse af proteinet til tidlig paavisning af draegtighed og fremgangsmaade til fremstilling af proteinet
DK0999849T3 (da)	2003-01-06	Anvendelse af LBP til sepsisbehandling
SE0003099D0 (sv)	2000-09-01	Adhesive protein and uses therefore
DE69836226D1 (de)	2006-11-30	Ifn rezeptor 1 bindende proteine, dafür kodierende dna und verfahren zur regulierung der zellulären antwort auf interferone
MX9701904A (es)	1998-05-31	Proteinas de enlace de pka novedosas y usos de las mismas.
BRPI0216042B8 (pt)	2021-05-25	polipeptídeo capaz de se ligar a ang-2, vetor de expressão, célula hospedeira, composição farmacêutica, e, uso dos referidos polipeptídeos.